SCHEMBL7914860

SCHEMBL7914860

CCOC(=O)c1ccc(-c2nnc(Nc3cccc(Cl)c3)c3ccccc23)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 11/20 0.71
MAPT P10636 4/20 0.64
KDM4E B2RXH2 1/20 0.64
PDE5A O76074 1/20 0.64
ALDH1A1 P00352 1/20 0.64
CYP1A2 P05177 1/20 0.64
CYP3A4 P08684 1/20 0.64
CYP2D6 P10635 1/20 0.64
CYP2C9 P11712 1/20 0.64
HPGD P15428 1/20 0.64
ALOX15 P16050 1/20 0.64
CYP2C19 P33261 1/20 0.64
PDE1A P54750 1/20 0.64
PDE1B Q01064 1/20 0.64
PDE3B Q13370 1/20 0.64
PDE1C Q14123 1/20 0.64
PDE3A Q14432 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
HSD17B10 Q99714 1/20 0.64
RXFP1 Q9HBX9 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL788175 0.90 KDR (0.78) KDRMAPTKDM4EPDE5AALDH1A1
SCHEMBL7905062 0.88 RXFP1 (0.71) KDRMAPTKDM4EALDH1A1CYP1A2
SCHEMBL7912189 0.86 KDR (0.62) KDRMAPTRXFP1TP53NPSR1
SCHEMBL8011266 0.85 MAPT (0.68) KDRMAPTKDM4EPDE5AALDH1A1
SCHEMBL7915100 0.84 KDR (0.72) KDRMAPTALDH1A1RXFP1NPSR1
SCHEMBL7918565 0.84 KDR (0.81) KDRMAPTKDM4EPDE5AALDH1A1
SCHEMBL7904939 0.84 RXFP1 (0.58) KDRMAPTKDM4EALDH1A1CYP1A2
SCHEMBL7918457 0.83 MEN1 (0.60) KDRMAPTKDM4EALDH1A1HPGD
SCHEMBL7912018 0.82 KDR (0.74) KDRMAPTALDH1A1SMN1; SMN2RXFP1
SCHEMBL7912100 0.81 MAPT (0.81) KDRMAPTKDM4EPDE5AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207666-B1 TREATING PRECANCEROUS LESIONS BY ADMINISTERING 4-PHENYLPHTHALAZINE DERIVATIVE CELL PATHWAYS, INC. 2001-03-27 US disclosed